tiprankstipranks
Medicinova (MNOV)
NASDAQ:MNOV
US Market
MNOV
Medicinova
RESEARCH TOOLSreports
Want to see MNOV full AI Analyst Report?

Medicinova (MNOV) Ratios

319 Followers

Medicinova Ratios

MNOV's free cash flow for Q1 2026 was $0.07. For the 2026 fiscal year, MNOV's free cash flow was decreased by $ and operating cash flow was $-15.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 9.09 8.16 13.88 15.61 18.51
Quick Ratio
 9.09 8.16 13.88 15.61 18.51
Cash Ratio
 8.83 8.11 13.64 15.55 5.81
Solvency Ratio
 >-0.01 -2.98 -3.27 -2.20 -3.59
Operating Cash Flow Ratio
 >-0.01 -2.58 -3.60 -2.27 -4.05
Short-Term Operating Cash Flow Coverage
 -0.06 -50.48 0.00 0.00 0.00
Net Current Asset Value
$ 24.85B$ 26.97M$ 37.70M$ 47.28M$ 55.07M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.08 1.10 1.06 1.06 1.06
Debt Service Coverage Ratio
 -0.08 -61.64 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 2.45 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 3.36 <0.01 <0.01 <0.01 0.01
Net Debt to EBITDA
 2.15K 2.56 3.17 5.14 1.22
Profitability Margins
Gross Profit Margin
15.20%7.58%0.00%100.00%0.00%
EBIT Margin
-2115.21%-2927.32%0.00%-990.03%0.00%
EBITDA Margin
-2115.55%-2922.41%0.00%-988.00%0.00%
Operating Profit Margin
-2164.84%-3242.47%0.00%-990.03%0.00%
Pretax Profit Margin
-1963.34%-2927.32%0.00%-856.85%0.00%
Net Profit Margin
-1964.35%-2928.78%0.00%-857.15%0.00%
Continuous Operations Profit Margin
-1964.35%-2928.78%0.00%-857.15%0.00%
Net Income Per EBT
100.05%100.05%100.05%100.04%100.02%
EBT Per EBIT
90.69%90.28%87.13%86.55%96.16%
Return on Assets (ROA)
-0.03%-26.31%-19.78%-12.93%-18.97%
Return on Equity (ROE)
-0.12%-28.85%-21.05%-13.74%-20.03%
Return on Capital Employed (ROCE)
-0.03%-31.77%-23.95%-15.72%-20.61%
Return on Invested Capital (ROIC)
-0.03%-31.63%-23.87%-15.66%-20.57%
Return on Tangible Assets
-0.04%-33.33%-26.64%-16.53%-23.54%
Earnings Yield
-17.38%-18.67%-10.73%-11.65%-13.99%
Efficiency Ratios
Receivables Turnover
 <0.01 0.00 0.00 0.00 0.00
Payables Turnover
 <0.01 0.61 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 <0.01 2.13 0.00 1.61 0.00
Asset Turnover
 <0.01 <0.01 0.00 0.02 0.00
Working Capital Turnover Ratio
 <0.01 0.01 0.00 0.02 0.00
Cash Conversion Cycle
 -464.95K -602.53 0.00 0.00 0.00
Days of Sales Outstanding
 149.94K 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 614.89K 602.53 0.00 0.00 0.00
Operating Cycle
 149.94K 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.19 -0.20 -0.22 -0.15 -0.26
Free Cash Flow Per Share
 -0.19 -0.20 -0.22 -0.15 -0.26
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -877.12 0.00 -11.89K -348.89 -2.58K
Capital Expenditure Coverage Ratio
 -877.12 0.00 -11.89K -348.89 -2.58K
Operating Cash Flow Coverage Ratio
 -0.06 -50.48 -54.93 -34.41 -18.96
Operating Cash Flow to Sales Ratio
 -15.92 -23.95 0.00 -7.43 0.00
Free Cash Flow Yield
-14.10%-15.26%-10.33%-10.13%-12.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.75 -5.36 -9.32 -8.58 -7.15
Price-to-Sales (P/S) Ratio
 113.02 156.89 0.00 73.57 0.00
Price-to-Book (P/B) Ratio
 <0.01 1.55 1.96 1.18 1.43
Price-to-Free Cash Flow (P/FCF) Ratio
 -7.09 -6.55 -9.68 -9.87 -7.78
Price-to-Operating Cash Flow Ratio
 -7.10 -6.55 -9.68 -9.90 -7.79
Price-to-Earnings Growth (PEG) Ratio
 15.88 -1.23 -0.26 0.21 -0.19
Price-to-Fair Value
 <0.01 1.55 1.96 1.18 1.43
Enterprise Value Multiple
 2.15K -2.81 -4.97 -2.31 -5.66
Enterprise Value
 -27.10B 33.66M 62.83M 22.79M 82.72M
EV to EBITDA
 2.15K -2.81 -4.97 -2.31 -5.66
EV to Sales
 -45.42K 82.17 0.00 22.79 0.00
EV to Free Cash Flow
 2.85K -3.43 -5.90 -3.06 -6.40
EV to Operating Cash Flow
 2.85K -3.43 -5.90 -3.07 -6.41
Tangible Book Value Per Share
 605.57 0.65 0.78 0.98 1.14
Shareholders’ Equity Per Share
 800.61 0.85 1.07 1.27 1.43
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.01 <0.01 0.00 0.02 0.00
Net Income Per Share
 -0.24 -0.24 -0.23 -0.17 -0.29
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.93 1.00 0.87 0.87 0.96
Research & Development to Revenue
 2.13K 17.47 0.00 5.66 0.00
SG&A to Revenue
 2.67K 15.04 0.00 4.98 0.00
Stock-Based Compensation to Revenue
 0.91 2.02 0.00 0.71 0.00
Income Quality
 0.81 0.82 0.96 0.87 0.92
Currency in USD